Marshall Wace, LLP Beyond Spring Inc. Put Options Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BYSI
# of Institutions
18Shares Held
5.26MCall Options Held
12.1KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.88MShares$8.64 Million1.71% of portfolio
-
Black Rock Inc. New York, NY215KShares$381,1780.0% of portfolio
-
Ubs Group Ag58.1KShares$102,8210.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$52,1670.11% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$43,1310.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $68.9M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...